To evaluate changes in frequency of orthostatic blood pressure (BP) reduction (orthostatic hypotension; OHI in elderly hypertensive patients (HT) before and after treatment for hypertension, we measured BP after supine for 10 min and standing position for 2 min, before and after treatment for 2 years by five kinds of antihypertensive drugs in 50 elderIy normotensive subjects (NT) and each of 50 HT in double-blind study. Orthostatic hypotension was defined as 10% or more decline of supine rthostatic blood pressure reduction or orthostatic hypotension (OH) has been widely investigated, but the precise mechanism and prevalence have not yet been clarified. However, the Systolic Hypertension in the Elderly (SHEP) study' and Cardiovascular Health Stuay (CHS) Collaborative Kesearch Groups' have reported that OH is common in the elderly subjects, and increases with advancing age, with increasing mean systolic blood pressure (BP), and with decreas- ing mean body mass index. In addition, they reported the prevalence of OH was 18.2% in elderly subjects, 12.0% in systolic hypertensive Fatients and the other investigators3 reported that is 20% in the subjects over 65 years and 30% in the subjects over 75 years as OH was deSned as a decline of 20 mm Hg or more in systolic BP or 10 mm Hg or more in diastolic BP. However, the prevalence of OH as a function of BP status is not clear, because the subjects in these reports were inc!uding normotensive (NT! and hypertensive (HT) subjects at various ratios. Furthermore, there are few studies about the prevalence of OH comparing before and after medications for hypertension?> Strogatz et al4 reported that some snrdies of the institutionalized elderly are more likely to include individuals with impairments or on medications that may cause postural hypotension, and that, therefore, tend to suggest a relatively high prevalence, and alternatively investigations designed to exclude those with hypertensive condition or on medications have found a low prevalence of postural hypotension. However, they classified antihypertensive medications into or&-
ing mean body mass index. In addition, they reported the prevalence of OH was 18.2% in elderly subjects, 12.0% in systolic hypertensive Fatients and the other investigators3 reported that is 20% in the subjects over 65 years and 30% in the subjects over 75 years as OH was deSned as a decline of 20 mm Hg or more in systolic BP or 10 mm Hg or more in diastolic BP. However, the prevalence of OH as a function of BP status is not clear, because the subjects in these reports were inc!uding normotensive (NT! and hypertensive (HT) subjects at various ratios. Furthermore, there are few studies about the prevalence of OH comparing before and after medications for hypertension?> Strogatz et al4 reported that some snrdies of the institutionalized elderly are more likely to include individuals with impairments or on medications that may cause postural hypotension, and that, therefore, tend to suggest a relatively high prevalence, and alternatively investigations designed to exclude those with hypertensive condition or on medications have found a low prevalence of postural hypotension. However, they classified antihypertensive medications into or&-two categories: diuretics or other antihypertensive medications. Furthermore, they gave no information concerning the duration of taking medications. In addition, their definition for postural hypotension was a reduction of 10 mm Hg or greater in systolic BP on going from sitting to standing while we defined OH as 10 .; or greater reduction of MBP from the supine to standil1.g position.
The present study wab co&~fe~ to evaluate the mechanism and the prevalence of OH before and atter medications for hypertension, by calcium channel blocker, P-blocker, a-blocker, angiotensin converting enzyme inhibitor, or diuretics, which are used commonly in Japan, in elderly established hypertensive patients.
MATERIALS AND METHODS
Fifty elderly (~65 years old) normotensive, each group of 50 elderly established hypertensive subjects, who were treated for hypertension by calcium channel blocker, P-blocker, a-blocker, angiotensin converting enzyme inhibitor, or diuretics, were age-, weight-, and body mass index-matched strictly (7625, 7326, 7427, 751t7, 7425, 78+-g years, 22.920.4, 22.720.5, 22.620.3, 22.950.4, 22.820.5, 22.820 .5 kg/ m 2, meantSD, respectively). Normotension was defined as c-140 / 90 mm Hg, and established hypertension was defined as >160 / 95 mm Hg at three or more measurements. All subjects were untreated preceding this study and without severe cardiovascular complicatior!s except hy?cr&nsion and without diabetes, I and WHO stages for hypertension were 1 or II. Following a I month placebo run-in period, antihypertensive medication of calcium channel blocker (nifedipineretard 40 mg / day, twice a day), fi-blocker (metoprc-10180 mg / day, twice a day), angiotensin converting enzyme inhibitor ( enalapril 10 mg / day, twice a day), a-blocker (prazosin 3 mg/ day, three times a day), and diuretics (thiazide 4 mg / day, twice a day j were done in double-blinded study. Blood pressure, pulse rate, and plasma norepinephrine (NE) level were measured after sitting for 5 min, supine rest for 10 min and standing posture for 2 min (in this order) after overnight fasting at before treatments and after treatments 1 month, 3 months, 1 year, and 2 years. OH was defined as a dec!ine of 10% or more in supine mean BP and 20 / 10 mm Hg or more in supine BP.
Statistical analyses were performed using x2 test, Tukey's method, paired t test, and unpaired f test. A P value of less than 5% was considered significant.
RESULTS
Age and body mass index in each group were not different and the stages of hypertension in each group were not different. The incidence of OH by definition of OH as a decline of 10% or more in supine mean BP is shown in Figure 1 . According to our definition of orthostatic hypotension as a decline of 10% or more in the supine mean BP, OH was recognized in 27% of hypertensive patients and 22% of normotensive subjects, while we used the definition of OH as a decline of 20,' 1.0 mm Hg or more, OH wes also recognized in 20% of hypertensive and 4% of normotensive subjects before medication. Orthostatic hypotension after 1 year of medication for hypertension was recognized in 22% and 4% of -NT, and 4% and 1% of HT by the definition of 10% or more, and by the definition of 20 / 10 mm Hg, respectively. However, there were no significant differences in the frequency of OH between NT and HT by either definition of OH (prcmedications: NT v HT P = .146 by the definition of 10% or more, and P = .159 by the definition of 20/ 10 mm Hg; post-medications: P = .069 by the definition of 10% or more, P = .406 by the definition of 20 / 10 mm Hg, by x2 test). On the other hand, frequency of OH in HT after 1 year of medication decreased significantly by both defir&ions. Furthermore, after medications of any antihypertensive drugs, the incidence of OH decreased significantly. In particular, metoprolol, enalapril and nifedipine made the incidence of OH to decrease significantly; metoprolol: 26% (before medication), 16% (1 month), 10%' (3 months), 2%t(l year), O%t(2 years), enalapril: 28%, 8%+, 8%*, O%t, O%t, rCfedipine: 26%,, 16%, 6%*, 4%*, 4% *, thiazide: 26%, 20%, 16%, 14%, iO"0, prazosin: 28%, 28%, 26%, 21%,19%, as a definition of OH as a decline of 10% or more in supine mean BP. The incidence of OH by definition of OH as a decline of i0 / 10 mm Hg or more was as follows: NT: 4%, h%, 4%, 4%, 4%; nifedipine: 22%, 8%*, 4%, O%t, O%t; metoproloi: 20%, IO%*, IO%*, O%t, O%t; enalapril: 18%, 6%*, 6%', O%t, O%t; prazosin: 18%, 12%, l2%, lo%, 10%; thiazide: 22%, 6%; lo%, 8%, 6%. The reduction of frequency of OH was noted as the number of subjects increased, whose systolic BP was less than 140 mm Hg and those with BP still higher than 140 mm Hg continued to have OH (Figures 2 and 3 1. Even prazosin, which is well known for the side effect of OH, decreased the incidence of OH. In all subjects, supine systolic BP correlated significantly with systolic BP, diastolic BP and mean BP before and after medication (premeditations: r = 0.40, P = .OOOl, r = 0.46, P = .OOOl, r = 0.48, P = .OOOl; postmedications (at 1 year): r = 0.44, P = .OOOl, r = 0.30, P = .OOOS, r = 0.41, P = .OOOl, respectively). in the present study, none of the subjects who showed OH were symptomatic such as dizziness, fainting, etc. both before and after medications, eve3 in the case of prazosin.
Supine plasma NE before medications was slightly * indicates P < .05, t indicates P < .Oi compared with the basal incidence. greater in hypertensive patients thai L in normotensive subjects (normotensives: 220 + 40 pg/mL, hypertensives: 280 + 50 pg /mL<), and in both normotensive and hypertensive subjects with OH were significantly greater than in the subjects without OH (normotensives with OH: 250 z 40 pg /mL, normotensives without OH: 210 2 30 pg/mL, (P < .05), hypertensives with OH: 330 + 40 pg /mL, hypertensives without OH: 260 2 40 pg/mL (P < .05), mean + SD). Supine and standing plasma NE levels after medications were slightly greater in hypertensive patients and significantly greater in the subjects with OH also than in normotensive subjects and the subjects without OH as well as the plasma NE status before medications. Standing NE before medication were also greater in hypertensive patients than in normotensive subjects (normotensives: 470 2 50 pg/mL, hjrpertensives: 521) i 50 pgfmL, P < .05) and in both normotensive and hypertensive subjects with OH were greater than those in the subjects without OH (NT with OI1: 510 t 50 pg /mL, NT without OH: 460 f-40 pg/mL (P < .051, I-IT with OII: 530 + 40 pg/mL, HT withaut OH: 510 + 40 pg/mL (N'S)). After 1 year of medication: supine NE: normotensives: 230 ? 40 pg /mI, hypertensives: 300 t 60 pg /mL; NT with OH: 250 I 40 pg/mLI NT without OH: 22G t 30 pg /mL, HT with OH: 4% t 5C pg/mL, HT -ithout CW 300 t 40 pg /mL; standing NE: normotensives: 480 i 50 pg /mL, hypertensiaes: 560 2 50 pg /mL; NT with 0.I-h 540 + 40 pg/mL, &XT without OH: 510 L 30 pg/ mL, HT with OH: 580 F 70 pg/mL, HT without (3H: 560 ? 50 pg/mL. Furthermore, the ratio of standing NE/supine NE in the subjects with OH regardless of BP status or any kind of medications was less than in the subjects without OH. Ratio of standing NE/supine NE before treatment were 2.2 of: 0.4 in NT with OH, 2.4 i 0.3 in NT without OH; 1.6 t 0.3 in HT with OH, and 2.0 i 0.2 in HT without OH, and after treatment 2.1 + 0.2 in NT with OH, 2.3 t 0.2 in XI without OH, 1.5 I 0.3 in KT with OH and 1.9 20.4 in HT without OH.
DISCUSSION
In this study, we tried to examine the Irevalence and mechanism in orthostatic BP reduction in parricular relation to BP status and to sympathetic nerve activity. Our results indicate that in elderly subjects OH was common and increased with advancing age and BP ent levels as a decline of 10% or more in supine mean levels, and these results were in good accordance with BP and 20 / IO mm Hg or more in supine BP. Although those in SHEI' study,' the CHS Collaborative Re-there are mainly reports in which OH was defined as search Group,' and our previous study.6 Some investigators',2~* a decline of 20/10 mm Hg or more in sitting BP or reported that the incidence of OfI was also supine BP, we thought that an absolute value of 20 / negatively correlated with body mass index. How-10 mm Hg may be inappropriate because the basal ever, we could not verify this phenomenon, because BPS between normotensives and hypertensives are in the present study, body mass index was matched significantly different. Therefore, we used the percentstrictly. Furthermore, we recognized that in elderly age decline of BP to compare the incidence of OH hypertensives patients, the prevalence of OH de-between normotensive and hypertensive subjects. creased with reducing BP levels by medications and Furthermore, we used the BP and plasma NE levels that the changes in BPS from supine to standing posi-after standing position for 2 mm, rather than 1 or 3 tion correlated significantly to supine BP. These re-min, because we have reported that the maximum sults support the concept that factors siguificantly as-changes in plasma NE from supine to standing Eosisociated with the presence of OH were higher mean systolic BI'r and elevated sitting BP.4 tion were recognized at 2 min after standing position in young hypertensive patients7 We defined orthostatic BP reduction in two differIt is known that plasma NE, as an index of sympa-
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Supine Systolic Blood Pressure (mm#g) thetic nerve activity, increases with aging' and that plasma NE responses to a change in position are increased in normotensive healthy elderly subjects, although cardiac responsiveness to sympathetic stimulation is diminished.' On the other hand, in elderly hypertensive patients, plasma NE does not increase in association with aging, and our previous findings indicate that plasma NE response to upright posture is blunted.7*8 Recently, E&z et al and Mark et al reported that NE spillover10~"~'2 or muscle sympathetic nerve activityI is better than plasma NE concentration to indicate an index of sympathetic nerve activity, and that head-up tilting typically reduced the rate of norepinephrine clearance form plasma.'" However, they also reported that the spillover of NE was different in each organ, and that plasma NE concentration showed partly the sympathetic nerve activity in whole body. Anderson et alI3 reported also that the muscle sympathetic nerve activity and biood fiotv were different between arm and leg muscle during mental stress. For this reason, in this study we used plasma NE concentration as an index of sympathetic nerve activity, and also because plasma _NE concentrations are convenient to measure in many subjects on numerous occasions.
In the present study, basal srpine plasma NE is greater in hypertensive patients and in subjects with OH, and plasma NE response to upright posture is blunted in elderly hypertensive patients and in subjects with OH regardless of hypertension medications. These results agree with our previous study" and the NE spillover study fur postural change by Esler et al." En the present study, metoprolol, enalapril and nifedipine had stronger effects in reducing OH inci-dence after long-term (more than 3 riiomhsl medication use than did thiazide or prazosin, particularly after ! year of medication. These differences might be caused by the differences in the mechanisms of BP reduction, especially due to the effects on sympathetic nerve activity, because in the acute medicated phase, &blockers and angiotensin converting enzyme (ACE! inhibitors have suppressive effects on the sympathetic nerve activity, and diuretics stimulate sympathetic nerve activity. However, these effects may exist only in the acute phase but not in the chronic phase. Therefore other mechanisms, such as the effects of blood pressure reduction itself on the central control of circulation, should be considered. On the other hand, prazosin may affect baroreceptor reflex mechanism by its own peripheral sympathetic blocking action resulting in the persistent postural blood pressure reduction.
Our findings that the incidence of OII decreased followed by decreasing BP and normalizing BP by antihypertensive drugs (especially &blockers, calcium antagonists, and ACE inhibitors 1 in elderly hy pertensive patients may indicate that some of hypertension-associated blunted mechanism of BP regulation predisposes orthostatic BP reduction in elderly hypertensive patients. Some investigators reported also that OH may result from age-related physiological change, age-associated disease or impaired homeostatic mechanisms of blood pressure regulation,'* impaired hemodynamic mechanisms or blunted p-adrenergic reactivity and a Fredominance of o-adrenergic vascular reactivity.'5
In conclusion, hypertension and the biunted sympathetic nerve activity may play some important roles in the development of frequent orthostatic hypotension in the elderly hypertensives.
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